Takeda Pharmaceutical - Primary Care Portfolio - Ownership and Business Overview

Medical ProductsCompany

Takeda Pharmaceutical - Primary Care Portfolio Ownership

Who owns Takeda Pharmaceutical - Primary Care Portfolio?

Takeda Pharmaceutical - Primary Care Portfolio is owned by Acino International AG. It was acquired on October 15, 2019.

Takeda Pharmaceutical - Primary Care Portfolio Business Overview

Where is Takeda Pharmaceutical - Primary Care Portfolio headquartered?

Takeda Pharmaceutical - Primary Care Portfolio is headquartered in Osaka, Japan.

What sector is Takeda Pharmaceutical - Primary Care Portfolio in?

Takeda Pharmaceutical - Primary Care Portfolio is a medical products company.

Medical Products M&A Summary in 2019

Out of 60 sectors in the Mergr database, medical products ranked 13 in number of deals in 2019. The largest medical products acquisition in 2019 was Acelity - which was acquired by 3M Company for $6.7B.

Join Mergr to view all 202 acquisitions of medical products companies in 2019, including 28 acquisitions by private equity firms, and 174 by strategics.

Takeda Pharmaceutical Co.,Ltd. - Primary Care Portfolio

Osaka, 540-8645
Japan,

Takeda’s primary care portfolio includes pain management, gastroenterology, cardiovascular and respiratory and other 30 products.


 Subscribe to unlock this and 202,314
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 194K M&A Transactions
  • 198K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Takeda Pharmaceutical - Primary Care Portfolio

Medical Products Companies , Japan Companies